Canaccord: Aldeyra Has Potentially 'Huge Catalysts,' Could More Than Double
July 01, 2015 at 09:41 AM EDT
In a report published Wednesday, Canaccord Genuity analyst Corey Davis initiated coverage of Aldeyra Therapeutics Inc (NASDAQ: ALDX) ...